By targeting a hub of schizophrenia-related genes, Northwestern Medicine scientists were able to correct a disease-related alteration in mouse model neurons.
Craig Johnson, MBA, has been appointed chief operating officer at the Feinberg School of Medicine.
New Northwestern Medicine research has shown that reprogrammed stem cells can be used to identify patients with cancer who are likely to experience a dangerous side effect of a common chemotherapy drug.
Marianne Green, MD, has been named senior associate dean for Medical Education, effective September 1.
Spotlighting some of the many awards and honors recently earned by Feinberg faculty members.
The latest government guidelines for diabetes screening missed 55 percent of high-risk individuals with prediabetes or diabetes, a new Northwestern Medicine study found.
Transplant surgeon Jason Wertheim, MD, PhD, participated in the White House Organ Summit, convened to increase access to organ transplants, reduce the organ waiting list and eventually develop new regenerative medicine technologies.
New research describes a never-before-observed identity switch in differentiated cells derived from so-called induced pluripotent stem cells.
A new study, led by scientists at the Rehabilitation Institute of Chicago, helps explain the phenomenon of movement chunking, which has important implications for the treatment and rehabilitation of patients with neurological disorders.
In collaboration with four local institutions, Northwestern University will receive $51 million over 5 years via the National Institutes of Health to help launch the Cohort Program of President Obama’s Precision Medicine Initiative.